Gibson Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, and Ropes & Gray advised Sarepta Therapeutics. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a global...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Lifespan on the transaction. Lifespan, a leading healthcare system in Rhode Island, to finalize an agreement to purchase Saint Anne’s Hospital in...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Crosspoint Capital Partners on the deal. Crosspoint Capital Partners acted as leading investor in a €65 million Series A follow-on funding round...
You must be a Standard 1 Year member to access this content.
